Gemina, Scarlyte B.

HRN: 23-28-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
AMPICILLIN 250MG (VIAL)
07/04/2023
07/10/2023
IVT
150mg
Q6hrs
Pcap C; AGE With Mod DHN
Waiting Final Action 
07/05/2023
AMPICILLIN 500MG (VIAL)
07/05/2023
07/12/2023
IV
300mg
Q6hours
PCAP-C
Waiting Final Action 
07/06/2023
MUPIROCIN 2%, 15G (TUBE)
07/06/2023
07/12/2023
TOPICAL
Apply To Rashes
BID
Diaper Rash
Waiting Final Action 
07/07/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
07/07/2023
07/14/2023
PO
1.8ml
BID
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: